3171 results for «3282»

Filter By

3171 results

Optimise your TAVI patient's outcomes: implementing the Edwards benchmark programme

20 May 2021 – From EuroPCR 2021

Watch this session presented by Simon Kennon, Olivier Darremont, Helene Eltchaninoff, Derk Frank, Sandra Lauck and Francesco Saia in order to improve access to high quality of care with safe early discharge for selected patients in Europe, to identify strategies to reduce hospital stay and optimise TAVI programmes for...

Optimise your TAVI patient's outcomes: implementing the Edwards benchmark programme

Paclitaxel and sirolimus coated balloons: create evidence before claims

20 May 2021 – From EuroPCR 2021

Watch this session presented by Mohd Ali Rosli, Bruno Scheller, Raban Jeger and Sylvia Otto in order to join a controversial discussion about a sirolimus and paclitaxel coated balloon approach, to follow a dedicated discussion on existing evidence on efficacy and safety for paclitaxel and sirolimus coated balloons...

Paclitaxel and sirolimus coated balloons: create evidence before claims

Complications during radial access

14 Apr 2021 – From EuroPCR 2021

Watch this session to find out more about a life-threatening complication of radial access, together with a rare complication highlighting the need to respect the radial artery.

EuroPCR 2021 Complications during radial access

Complications during complex PCI

14 Apr 2021 – From EuroPCR 2021

Don't miss this session if you want to be prepared if you discover what you can least expect during complex PCI, or in case of uncommon complication during a complex PCI procedure.

EuroPCR 2021 Complications during complex PCI

HIGHLIFE transseptal mitral valve replacement (TSMVR): clinical study update

18 May 2021 – From EuroPCR 2021

Watch this session presented by Didier Tchetche in order to learn about the HighLife transseptal mitral valve replacement study status, to understand the complex patient population treated and first outcomes, and to be familiar with the current technology and future enhancements.

HIGHLIFE transseptal mitral valve replacement (TSMVR): clinical study update

Left heart suffering after successful TAVI

12 May 2021 – From EuroPCR 2021

In this session, analyze a rare case of cardiogenic shock after TAVR, get prepared in case of Takotsubo cardiomyopathy after transcatheter aortic valve-in-valve replacement, get hints for troubleshooting in treating left-sided obstructions, find out more about transfemoral TAVI and mitral clipping for prevention of a SAM-phenomenon, and more!

EuroPCR 2021 Left heart suffering after successful TAVI

Advanced techniques for complex CTO interventions (Part 2) - Session with LIVE demonstration

20 May 2021 – From EuroPCR 2021

Watch this session if you want to develop treatment strategies in a patient with multiple CTOs, to learn how to approach technical difficulties in complex CTO PCI, and to learn about treatment options for typical complications of CTO PCI.

This session was originally presented during EuroPCR 2021.

Advanced techniques for complex CTO interventions (Part 2)

EuroPCR 2021 Hotlines / Late-Breaking Trials: TRILUMINATE, CLASP TR, bRIGHT, TRISCEND, TriBAND, and more!

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in TRICUSPID:

  • Percutaneous E2E repair for TR: 2-Year outcomes from the TRILUMINATE trial
  • Transcatheter tricuspid valve repair: CLASP TR feasibility study 6-month results
  • Clinical Response to Transcatheter treatment of tricuspid regurgitation: International TriValve registry
  • Baseline characteristics and procedure outcomes from TriClip bRIGHT...
EuroPCR 2021 Hotlines / Late-Breaking Trials: TRILUMINATE, CLASP TR, bRIGHT, TRISCEND, TriBAND, and more!

Presentation of the PCR Tricuspid Focus Group

19 May 2021 – From EuroPCR 2021

This session was originally presented during EuroPCR 2021.

Presentation of the PCR Tricuspid Focus Group

Advanced techniques for complex CTO interventions (Part 1) - Session with LIVE demonstration

20 May 2021 – From EuroPCR 2021

Watch this session if you want to develop treatment strategies in a patient with multiple CTOs, to learn how to approach technical difficulties in complex CTO PCI, and to learn about treatment options for typical complications of CTO PCI.

This session was originally presented during EuroPCR 2021.

Advanced techniques for complex CTO interventions (Part 1)

EAPCI-PCR Fellows Course: interventions for calcified coronary lesions

18 May 2021 – From EuroPCR 2021

Watch this session if you want to review the role of imaging for procedural planning and  to discuss the best indications for specific plaque modification techniques.

This session was originally presented during EuroPCR 2021.

EAPCI-PCR Fellows Course: interventions for calcified coronary lesions

Meta-analysis of elective coronary revascularization vs medical therapy alone

18 May 2021 – From EuroPCR 2021

This session, originally broadcast during EuroPCR 2021, presents a meta-analysis based on 25 trials dealing with revascularization in patients with chronic coronary syndromes and enables our experts to discuss the strengths and weaknesses of this study.  

Meta-analysis of elective

Introducing Navitor: a new TAVI solution

18 May 2021 – From EuroPCR 2021

Watch this session presented by Helge Möllmann, Lars Sondergaard, Maurizio Taramasso, Ganesh Manoharan and Dave Smith in order to discuss how to minimise resources needed for your TAVI procedure without compromising safety and efficacy, to demonstrate how to simplify your TAVI procedure, and to examine considerations for lifetime management of your...

Introducing Navitor: a new TAVI solution

One-year results from the FUTURE-II trial

19 May 2021 – From EuroPCR 2021

This LBT session, which was originally presented during EuroPCR 2021, deals with the FUTURE-II study on the new generation of bioresorbable scaffolds, providing comparative safety and efficacy evidence of the thinner-strut PLLA-based BRS in the treatment of patients with noncomplex coronary lesions.

One-year results from the FUTURE-II trial

Complete 2-year follow-up from the Evolut low risk trial

18 May 2021 – From EuroPCR 2021

This session was originally presented during EuroPCR 2021.

Complete 2-year follow-up from the Evolut low risk trial

Why physiology and co-reg is helpful in treating patients with multivessel disease/diffused disease

20 May 2021 – From EuroPCR 2021

Watch this session presented by Sukhjinder Nijjer, Nick Curzen, Rasha Al-Lamee and Sayan Sen in order to learn about the new pressure guide wire OmniWire and workflow enhancement with Azurion and IntraSight, to understand how "interventional physiology" can guide PCI in diffuse, multivessel coronary artery disease, and to learn how...

Why physiology and co-reg is helpful in treating patients with multivessel disease/diffused disease

Sustained Limus release, redefining indications for drug-eluting balloons

20 May 2021 – From EuroPCR 2021

Watch this session presented by Bernardo Cortese, Kambis Mashayekhi, Jonas Häner and Tuomas Rissanen in order to understand how sustained Limus release technology can broaden DEB indications, to learn how SELUTION SLR sustained Limus DEB performs in daily clinical practice, and to know more about the importance of sustained Limus release technology...

Sustained Limus release, redefining indications for drug-eluting balloons

Coronary access after TAVI, a growing need

20 May 2021 – From EuroPCR 2021

Watch this session presented by Nicolas Van Mieghem, Christopher Meduri, Andreas Ruck, Nawzad Saleh, Joanna Wykrzykowska and Mohamed Abdel-Wahab in order to learn about the growing importance of coronary access after TAVI, to understand how TAVI design and implantation technique has an impact on future coronary access, and to discuss the...

Coronary access after TAVI, a growing need

Latest insights: when to choose orbital atherectomy

20 May 2021 – From EuroPCR 2021

Watch this session presented by Nicolas Van Mieghem, Surendra Avula and Ajay Kirtane in order to understand the challenges of treating severe calcium, to know about the OAS overview with dual-action MOA technology and the clinical evidence supporting its use, and to be introduced to treatment technique.

Latest insights: when to choose orbital atherectomy

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Andreas Baumbach and Patrick W. Serruys in order to understand what is a healing-targeted (HT) drug-eluting stent (DES) and what are the potential benefits, to review recent clinical data of the HT DES from the PIONEER III trial, and to learn about...

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?
Didn’t find what you were looking for?